Clinical Genomics


Clinical Genomics is the use of genome sequencing to inform patient diagnosis and care. The California Initiative to Advance Precision Medicine has just been launched, and it is being headed by UCSF’s high profile recent hire, Atul Butte.

The global market for Clinical Genomics is expected to reach USD 22.1 billion by 2020, growing at an estimated CAGR of 10.3% from 2014 to 2020, according to a new study by Grand View Research.



Genomic healthcare uses many pieces of genetic information to refine diagnoses, individualize treatments, prevent adverse drug effects, manage epidemics and develop new therapies. The incorporation of whole-genome and whole-exome sequencing into clinical practice will undoubtedly change the way genetic counselors and other clinicians approach genetic testing. Genomics play an imperative role in the field of infectious disease testing by enabling the use of fast and effective result rendering molecular diagnostic tests. Genomics based diagnostics dominated the overall market in terms of revenue at 36.4% in 2013 majorly owing to the presence of a relatively larger number of R&D programs.


    Related Conference of Clinical Genomics

    November 30-30, 2020

    Genetics and Molecular biology

    Paris, France
    December 07-08, 2020

    2nd World Congress on Cell and Structural Biology

    Sydney, Australia
    December 09-09, 2020

    International Conference on Toxicogenomics

    Bali, Indonesia

    Clinical Genomics Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in